You are here

  • Home
  • Archive
  • Volume 17, Issue 2
  • Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events

Article Text

Article menu
Download PDFPDF
Therapeutics
Systematic review and meta-analysis
Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events

https://doi.org/10.1136/ebm.2011.100198

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests SNR is an employee of Merck.